Author | Laurence Klotz, MD, FRCSC, CM

Articles

Active Surveillance for Prostate Cancer: How to Do It Right

May 15, 2017

In this review of active surveillance for favorable-risk prostate cancer, we will discuss the rationality of this approach, the biological evidence for employing active surveillance in Gleason pattern 3 and 4 prostate cancer, patient selection for active surveillance, clinical trial data on active surveillance, and the role of prostate cancer biomarkers and imaging studies for clinical decision making in patients with low-risk disease.

Active Surveillance Not Only Reduces Morbidity, It Saves Lives

June 15, 2013

The concept of active surveillance is based on the observation that Gleason 6 (pattern 3) prostate cancer is an indolent condition that poses little or no threat to the patient’s life. Conservative management is thus appropriate for these patients.